loading
前日終値:
$133.23
開ける:
$133.26
24時間の取引高:
159.61K
Relative Volume:
0.17
時価総額:
$13.35B
収益:
$2.41B
当期純損益:
$305.80M
株価収益率:
45.61
EPS:
2.95
ネットキャッシュフロー:
$492.20M
1週間 パフォーマンス:
+2.53%
1か月 パフォーマンス:
+2.12%
6か月 パフォーマンス:
+11.55%
1年 パフォーマンス:
-10.78%
1日の値動き範囲:
Value
$132.41
$134.79
1週間の範囲:
Value
$131.20
$134.79
52週間の値動き範囲:
Value
$84.23
$154.87

Neurocrine Biosciences Inc Stock (NBIX) Company Profile

Name
名前
Neurocrine Biosciences Inc
Name
セクター
Healthcare (1161)
Name
電話
(858) 617-7600
Name
住所
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA
Name
職員
1,800
Name
Twitter
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
NBIX's Discussions on Twitter

NBIX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
134.63 13.21B 2.41B 305.80M 492.20M 2.95
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.75 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.34 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.825 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.50 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
310.94 14.21B 2.99B 1.21B 1.13B 25.06

Neurocrine Biosciences Inc Stock (NBIX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-21 開始されました Truist Buy
2025-07-10 開始されました Goldman Buy
2025-04-15 アップグレード Needham Hold → Buy
2025-04-14 アップグレード RBC Capital Mkts Sector Perform → Outperform
2025-02-11 開始されました Deutsche Bank Hold
2024-10-10 再開されました Raymond James Outperform
2024-08-29 アップグレード Piper Sandler Neutral → Overweight
2024-04-24 アップグレード Wells Fargo Equal Weight → Overweight
2023-12-13 再開されました Citigroup Neutral
2023-12-12 開始されました Deutsche Bank Buy
2023-10-24 再開されました Cantor Fitzgerald Overweight
2023-08-21 繰り返されました Mizuho Neutral
2023-07-24 アップグレード SVB Securities Market Perform → Outperform
2023-07-06 アップグレード BMO Capital Markets Underperform → Market Perform
2023-05-04 アップグレード Guggenheim Neutral → Buy
2023-03-30 アップグレード Canaccord Genuity Hold → Buy
2023-03-03 アップグレード Evercore ISI In-line → Outperform
2023-02-03 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-11-14 ダウングレード Evercore ISI Outperform → In-line
2022-10-11 開始されました UBS Buy
2022-09-26 開始されました Wells Fargo Equal Weight
2022-06-06 再開されました Jefferies Buy
2022-03-03 ダウングレード Piper Sandler Overweight → Neutral
2022-02-25 アップグレード Goldman Neutral → Buy
2022-01-18 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2021-11-19 開始されました BMO Capital Markets Underperform
2021-11-17 アップグレード JP Morgan Neutral → Overweight
2021-10-14 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-09-23 再開されました Needham Hold
2021-08-06 ダウングレード Canaccord Genuity Buy → Hold
2021-05-18 再開されました Goldman Neutral
2021-05-06 アップグレード Barclays Equal Weight → Overweight
2021-02-02 開始されました Raymond James Outperform
2020-09-30 開始されました The Benchmark Company Hold
2020-08-04 ダウングレード JP Morgan Overweight → Neutral
2020-06-29 ダウングレード Goldman Buy → Neutral
2020-06-09 開始されました Wedbush Outperform
2020-03-06 開始されました Citigroup Buy
2020-02-27 開始されました Barclays Equal Weight
2020-02-24 開始されました William Blair Outperform
2020-02-06 開始されました Mizuho Neutral
2020-02-05 繰り返されました H.C. Wainwright Buy
2019-12-13 ダウングレード Credit Suisse Outperform → Neutral
2019-08-07 開始されました RBC Capital Mkts Outperform
2019-07-16 開始されました Oppenheimer Outperform
2019-06-05 開始されました Guggenheim Neutral
2019-05-21 開始されました Credit Suisse Outperform
2019-04-22 アップグレード JP Morgan Neutral → Overweight
2019-04-12 開始されました Evercore ISI Outperform
2019-02-06 繰り返されました BofA/Merrill Buy
2019-01-23 ダウングレード JP Morgan Overweight → Neutral
2018-12-13 開始されました Goldman Buy
2018-11-21 開始されました Canaccord Genuity Buy
すべてを表示

Neurocrine Biosciences Inc (NBIX) 最新ニュース

pulisher
Aug 20, 2025

Singer Carnie Wilson and Dr. Greg Mattingly discuss tardive dyskinesia on Your Day - WKEF

Aug 20, 2025
pulisher
Aug 19, 2025

Will Neurocrine Biosciences Inc. stock go up soonTrend Reversal & AI Enhanced Execution Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Published on: 2025-08-20 04:48:02 - classian.co.kr

Aug 19, 2025
pulisher
Aug 19, 2025

Will Neurocrine Biosciences Inc. price bounce be sustainableEarnings Overview Report & Precise Trade Entry Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Long term hold vs stop loss in Neurocrine Biosciences Inc.Weekly Trading Summary & Daily Profit Focused Stock Screening - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How to integrate Neurocrine Biosciences Inc. into portfolio analysis toolsPortfolio Return Report & Precise Trade Entry Recommendations - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using portfolio simulators with Neurocrine Biosciences Inc. included2025 Performance Recap & Verified Trade Idea Suggestions - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Does Neurocrine Biosciences Inc. fit your quant trading modelJuly 2025 Action & Community Consensus Picks - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Real time scanner hits for Neurocrine Biosciences Inc. explainedRate Cut & Daily Profit Maximizing Trade Tips - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Relative strength of Neurocrine Biosciences Inc. in sector analysisPortfolio Performance Report & Reliable Intraday Trade Plans - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q1 2025 Earnings Call Transcript - MSN

Aug 18, 2025
pulisher
Aug 18, 2025

Order flow analysis tools used on Neurocrine Biosciences Inc.2025 Buyback Activity & Daily Profit Focused Screening - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Ranking Neurocrine Biosciences Inc. among high performing stocks via toolsWeekly Gains Summary & Breakout Confirmation Trade Signals - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Will Neurocrine Biosciences Inc. stock recover after recent dropJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Is Neurocrine Biosciences Inc. stock reversal real or fakeQuarterly Earnings Report & Weekly Market Pulse Updates - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Top chart patterns to watch in Neurocrine Biosciences Inc.Dollar Strength & AI Enhanced Trading Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

What’s the recovery path for long term holders of Neurocrine Biosciences Inc.2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-16 23:41:15 - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Understanding Neurocrine Biosciences Inc.’s price movementTrade Performance Summary & Fast Exit and Entry Strategy Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Truist Securities Initiates Coverage of Neurocrine Biosciences (NBIX) with Buy Recommendation - MSN

Aug 16, 2025
pulisher
Aug 16, 2025

Visual analytics tools that track Neurocrine Biosciences Inc. performancePortfolio Value Summary & Low Risk Entry Point Tips - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Reversal Traders Monitor Neurocrine Biosciences Inc. for EntryJuly 2025 Institutional & Weekly Sector Rotation Insights - metal.it

Aug 16, 2025
pulisher
Aug 16, 2025

Trendlines Converge — Decision Point for Neurocrine Biosciences Inc.July 2025 Recap & Stock Market Timing Techniques - beatles.ru

Aug 16, 2025
pulisher
Aug 16, 2025

Real time social sentiment graph for Neurocrine Biosciences Inc.2025 Big Picture & Technical Confirmation Alerts - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Earnings visualization tools for Neurocrine Biosciences Inc.2025 Price Targets & Precise Trade Entry Recommendations - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Published on: 2025-08-15 16:55:58 - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

PNC Financial Services Group Inc. Cuts Stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Defense World

Aug 15, 2025
pulisher
Aug 14, 2025

What Technical Tools Say About Neurocrine Biosciences Inc. RecoveryJuly 2025 Macro Moves & Weekly High Return Stock Opportunities - newsimpact.co.kr

Aug 14, 2025
pulisher
Aug 13, 2025

Neurocrine at Canaccord Conference: Strategic Growth and Innovation By Investing.com - Investing.com Canada

Aug 13, 2025
pulisher
Aug 13, 2025

US Bancorp DE Has $412,000 Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Defense World

Aug 13, 2025
pulisher
Aug 13, 2025

Stronger-Than-Expected Q2 Results Could Be a Game Changer for Neurocrine Biosciences (NBIX) - simplywall.st

Aug 13, 2025
pulisher
Aug 11, 2025

Neurocrine Biosciences Director Gorman Buys, Sells 106,322 Shares on 8/7/2025 - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Neurological Disorder Drugs Market Set to Witness Significant - openPR.com

Aug 11, 2025
pulisher
Aug 11, 2025

Will Neurocrine Biosciences Inc. bounce back from current supportWatchlist Summary for Active Day Traders - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

What’s next for Neurocrine Biosciences Inc. stock priceFree Daily Growth Stock Pick Reports - Newser

Aug 10, 2025
pulisher
Aug 08, 2025

Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025 - GlobeNewswire Inc.

Aug 08, 2025
pulisher
Aug 07, 2025

Neurocrine Biosciences shares rise 3.11% after-hours following Nxera Pharma's obesity pipeline progress. - AInvest

Aug 07, 2025
pulisher
Aug 06, 2025

This Neurocrine Biosciences Insider Reduced Their Stake By 28% - 富途牛牛

Aug 06, 2025
pulisher
Aug 06, 2025

Neurocrine Biosciences to Present at the Canaccord Genuity 45th Annual Growth Conference - Yahoo Finance

Aug 06, 2025
pulisher
Aug 06, 2025

Neurocrine Biosciences shares fall 1.10% intraday as Nxera Pharma launches obesity drug pipeline. - AInvest

Aug 06, 2025
pulisher
Aug 06, 2025

Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail

Aug 06, 2025
pulisher
Aug 05, 2025

Tardive Dyskinesia Drugs Market Exclusive Report with Detailed - openPR.com

Aug 05, 2025
pulisher
Aug 05, 2025

Neurocrine Biosciences (NASDAQ:NBIX) Upgraded at Wall Street Zen - Defense World

Aug 05, 2025
pulisher
Aug 05, 2025

Guggenheim Boosts Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $175.00 - MarketBeat

Aug 05, 2025
pulisher
Aug 04, 2025

CRENESSITY's Breakout Launch Might Change the Case for Investing in Neurocrine Biosciences (NBIX) - simplywall.st

Aug 04, 2025
pulisher
Aug 04, 2025

William Blair Analysts Increase Earnings Estimates for NBIX - Defense World

Aug 04, 2025
pulisher
Aug 03, 2025

What drives Neurocrine Biosciences Inc. stock priceUnlock powerful trading alerts for success - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Neurocrine Biosciences Inc. a growth stock or a value stockTremendous wealth creation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Neurocrine Biosciences Inc. Stock Analysis and ForecastRapid portfolio appreciation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Neurocrine Biosciences (NASDAQ:NBIX) Price Target Lowered to $144.00 at Royal Bank Of Canada - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

How does Neurocrine Biosciences Inc. generate profit in a changing economyMaximize portfolio value with smart investment plans - Jammu Links News

Aug 03, 2025

Neurocrine Biosciences Inc (NBIX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Neurocrine Biosciences Inc (NBIX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
GORMAN KEVIN CHARLES
Director
Aug 07 '25
Sale
126.41
106,322
13,440,281
514,596
$310.50
price up icon 1.17%
$10.67
price up icon 0.33%
drug_manufacturers_specialty_generic RDY
$14.39
price up icon 1.88%
$17.57
price up icon 0.60%
$18.50
price up icon 4.83%
大文字化:     |  ボリューム (24 時間):